Literature DB >> 24227978

Animal models in retinoblastoma research.

Rohini M Nair1, Swathi Kaliki, Geeta K Vemuganti.   

Abstract

Advances in animal models of retinoblastoma have accelerated research in this field, aiding in understanding tumor progression and assessing therapeutic modalities. The distinct pattern of mutations and specific location of this unique intraocular tumor have paved the way for two types of models- those based on genetic mutations, and xenograft models. Retinoblastoma gene knockouts with an additional loss of p107, p130, p53 and using promoters of Nestin, Chx10, and Pax6 genes show histological phenotypic changes close to the human form of retinoblastoma. Conditional knockout in specific layers of the developing retina has thrown light on the origin of this tumor. The use of xenograft models has overcome the obstacle of time delay in the presentation of symptoms, which remains a crucial drawback of genetic models. With the advances in molecular and imaging technologies, the current research aims to develop models that mimic all the features of retinoblastoma inclusive of its initiation, progression and metastasis. The combination of genetic and xenograft models in retinoblastoma research has and will help to pave way for better understanding of retinoblastoma tumor biology and also in designing and testing effective diagnostic and treatment modalities.

Entities:  

Keywords:  Knock-out genetic model; Preclinical models; Retinoblastoma; Xenograft models

Year:  2013        PMID: 24227978      PMCID: PMC3770224          DOI: 10.1016/j.sjopt.2013.06.008

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  59 in total

1.  Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma.

Authors:  T G Murray; D B Roth; J M O'Brien; W Feuer; N Cicciarelli; A M Markoe; E Hernández; B J Smith; J J Windle
Journal:  Arch Ophthalmol       Date:  1996-11

Review 2.  Modelling melanoma in mice.

Authors:  Graeme J Walker; H P Soyer; Tamara Terzian; Neil F Box
Journal:  Pigment Cell Melanoma Res       Date:  2011-11-02       Impact factor: 4.693

3.  Enumeration of the simian virus 40 early region elements necessary for human cell transformation.

Authors:  William C Hahn; Scott K Dessain; Mary W Brooks; Jessie E King; Brian Elenbaas; David M Sabatini; James A DeCaprio; Robert A Weinberg
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

Review 5.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

6.  Topotecan combination chemotherapy in two new rodent models of retinoblastoma.

Authors:  Nikia A Laurie; Jonathan K Gray; Jiakun Zhang; Mark Leggas; Mary Relling; Merrill Egorin; Clinton Stewart; Michael A Dyer
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  Embryonic retinal tumors in SV40 T-Ag transgenic mice contain CD133+ tumor-initiating cells.

Authors:  Lalita Wadhwa; Wesley S Bond; Laszlo Perlaky; Paul A Overbeek; Mary Y Hurwitz; Patricia Chévez-Barrios; Richard L Hurwitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-08       Impact factor: 4.799

9.  Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.

Authors:  Maria-Elena Jockovich; Fernando Suarez; Armando Alegret; Yolanda Piña; Brandy Hayden; Colleen Cebulla; William Feuer; Timothy G Murray
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-12       Impact factor: 4.799

10.  Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences.

Authors:  B O Williams; E M Schmitt; L Remington; R T Bronson; D M Albert; R A Weinberg; T Jacks
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  4 in total

Review 1.  Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.

Authors:  Eleanor M Pritchard; Michael A Dyer; R Kiplin Guy
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

2.  Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma.

Authors:  Andrea A Wenzel; Michael N O'Hare; Mehdi Shadmand; Timothy W Corson
Journal:  Mol Vis       Date:  2015-05-01       Impact factor: 2.367

3.  A short-term chick embryo in vivo xenograft model to study retinoblastoma cancer stem cells.

Authors:  Rohini M Nair; Narayana V L Revu; Sucharita Gali; Prathap Reddy Kallamadi; Varsha Prabhu; Radhika Manukonda; Harishankar Nemani; Swathi Kaliki; Geeta K Vemuganti
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

4.  Commentary: A short-term chick embryo in vivo xenograft model to study retinoblastoma cancer stem cells.

Authors:  Krishnakumar Subramanian
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.